---
title: "Propanc Biopharma Soars 47% During Regular Trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291556495.md"
description: "Propanc Biopharma (PPCB) jumped 47% to $2.11 with 15.76M shares traded, showing sharp volatility within 5 minutes."
datetime: "2026-07-02T13:41:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291556495.md)
  - [en](https://longbridge.com/en/news/291556495.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291556495.md)
---

# Propanc Biopharma Soars 47% During Regular Trading

Propanc Biopharma(PPCB.US) 盘中涨**46.53%**，现报**2.11 美元**。

### Related Stocks

- [PPCB.US](https://longbridge.com/en/quote/PPCB.US.md)

## Related News & Research

- [Propanc Biopharma signs MOU with Avance Clinical for PRP Phase 1b trial delivery](https://longbridge.com/en/news/291933222.md)
- [Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results | PPCB Stock News](https://longbridge.com/en/news/286567783.md)
- [Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade | PPCB Stock News](https://longbridge.com/en/news/287069272.md)
- [10:08 ETCellipont Bioservices and BobcatBio Announce Strategic Collaboration to Advance Macrophage Cell Therapy for Solid Tumors](https://longbridge.com/en/news/279448474.md)